Picture EBD Group BIO-Europe 2026 Köln Cologne to 31 Jul 650x100px

Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Ona Therapeutics Raises $86.6mSeries B to Advance ADCs (2026-06-04)
> Oversubscribed Series B financing co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors > Proceeds to support clinical development of lea...
DaltonTx Launches Platform and Partners with Sygnature (2026-06-04)
> Dalton is a drug discovery platform integrating agentic AI, human expertise, and experimental data, into one continuous learning engine > Announces collaboration with Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO)...
Lundbeck & Cradle Partner for AI-based Brain Disorder R&D (2026-06-03)
Collaboration’s initial focus will focus on two antibody programs targeting CNS diseases H. Lundbeck A/S (Lundbeck), a global biopharmaceutical company focused exclusively on brain health, and Cradle, a leading AI platform for protein engineering, today anno...
T-Curx GmbH Acquires Pantherna Therapeutics GmbH (2026-06-01)
T-CURX acquires Pantherna Therapeutics to leverage the complementary expertises and proprietary technologies of both companies to accelerate clinical translation of CAR-T strategies with a clear focus on clinical validation of in vivo CAR-T therapies. > T-CURX l...
Lilly to Acquire LimmaTech Biologics for up to $780m in Cash (2026-05-26)
> LimmaTech’s self-adjuvating and multi-antigen vaccine platform addresses common bacterial infections that currently cannot be prevented > Lead program focuses on Staphylococcus aureus infection, a common complication of surgical procedures LimmaTech Bio...
Lilly: 3 Acquisitions to Build Infectious Disease Portfolio (2026-05-26)
> Agreements with Curevo, LimmaTech Biologics and Vaccine Company address viral pathogens linked to long-term neurological and oncological risk, and bacterial pathogens that are difficult to prevent or treat > Acquisitions build on Lilly's infectious disease leg...
InSphero Acquires PhenoVista Biosciences to Expand in US (2026-05-20)
Strategic acquisition strengthens InSphero’s presence in the United States and expands advanced imaging and phenotypic analysis capabilities for drug discovery and safety testing InSphero, the global leader in advanced 3D in vitro models and services for dru...
Qiagen Announces Collaboration with Nvidia at Bio-IT World (2026-05-19)
> Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases > Goal to advance how disease mechanisms, therapeutic targets and biomarkers are identified > Graph-base...
Hansa Biopharma: €115m Licensing Agreement with SERB (2026-05-19)
> The agreement covers the European Union, United Kingdom, Switzerland, Norway, Liechtenstein, Iceland and the MENA region > Significantly enhances Hansa’s financial position, ensuring a robust U.S. launch and provides path to profitability, subject to US appr...
Lauxera Capital Partners Closes Growth II Fund at €520m (2026-05-19)
The oversubscribed second fund plans to deploy capital across 12 to 15 companies, with individual investments of €20 to €50 million focused on US and global market expansion. Lauxera Capital Partners, a growth-buyout and growth equity firm focused on innov...

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

Picture Berlin Partner News New Research Centers BeCat S-IM 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]